← All peptides
warningBioGate · AMBERGrade B

Octreotide (Sandostatin)

fCFwKTCT-ol

Synthetic octapeptide somatostatin analog; suppresses GH, insulin, glucagon, and gut peptides via SSTR2/SSTR5 binding.

D-Phe¹D-Trp⁴C-terminal threoninoldisulfide C2-C7
MW
1019.24
Length
11aa
Posterior
81.3%
Structural preview · ESMFold-2 mockdeterministic per sequence
Backbone preview · D-Phe¹
PDA-V1 attestation

Cryptographic chain of custody.

Outer PDA hash
Inputs hash
Merkle root
TEE attestation
Protocol version
PDA-V1
Source
peptide-md
Model version
structure-fm-2026.04
Candidates emitted
4
Signed
2026-04-21T08:14:33Z
Verifiable in your browser at /verifier with @peptide-md/verifier.
Real-world evidence

Cohort-attested outcomes.

Cohorts
7
Participants
115
Mean Δ
+5.7
Δ HRV ms (8-week) · 95% CI [4.75, 6.64]
IPNFT · Molecule IPNFT V2Solana
Octreotide (Sandostatin)
91100d…ad9410
Royalty cascade
13.64%
Holders
92
Royalty cascade routes lab fees, licensing, and OEA-attested cohort revenues back to holders, the cohort treasury, and the originating researchers in a 60 / 25 / 15 split.
Citations

Source literature.

Grade A1996 · N Engl J Med

Octreotide

Lamberts SWJ et al.

PMID 8602181